Kennedy Capital Management’s NewAmsterdam Pharma NAMS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$248K	Buy	+13,675	New	+$248K	0.01%	556
2025 Q1	–	Sell	-7,945	Closed	-$204K	–	682
2024 Q4	$204K	Sell	7,945 -6,101	-43%	-$157K	﹤0.01%	660
2024 Q3	$233K	Buy	14,046 +2,193	+19%	+$36.4K	0.01%	670
2024 Q2	$228K	Buy	+11,853	New	+$228K	﹤0.01%	679